NO20051941L - Kombinasjonskjemoterapisammensetninger og fremgangsmater. - Google Patents
Kombinasjonskjemoterapisammensetninger og fremgangsmater.Info
- Publication number
- NO20051941L NO20051941L NO20051941A NO20051941A NO20051941L NO 20051941 L NO20051941 L NO 20051941L NO 20051941 A NO20051941 A NO 20051941A NO 20051941 A NO20051941 A NO 20051941A NO 20051941 L NO20051941 L NO 20051941L
- Authority
- NO
- Norway
- Prior art keywords
- methods
- combination chemotherapy
- compositions
- chemotherapy compositions
- combination therapies
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0086—Platinum compounds
- C07F15/0093—Platinum compounds without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2002951833A AU2002951833A0 (en) | 2002-10-02 | 2002-10-02 | Compositions and therapeutic methods invloving platinum complexes |
| PCT/AU2003/001296 WO2004030662A1 (en) | 2002-10-02 | 2003-10-02 | Combination chemotherapy compositions and methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20051941L true NO20051941L (no) | 2005-04-20 |
Family
ID=28679466
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20051941A NO20051941L (no) | 2002-10-02 | 2005-04-20 | Kombinasjonskjemoterapisammensetninger og fremgangsmater. |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7906554B2 (de) |
| EP (1) | EP1545481A4 (de) |
| JP (1) | JP2006504705A (de) |
| CN (1) | CN100591331C (de) |
| AU (1) | AU2002951833A0 (de) |
| CA (1) | CA2498555A1 (de) |
| MX (1) | MXPA05003528A (de) |
| NO (1) | NO20051941L (de) |
| NZ (1) | NZ538583A (de) |
| WO (1) | WO2004030662A1 (de) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0011903D0 (en) * | 2000-05-18 | 2000-07-05 | Astrazeneca Ab | Combination chemotherapy |
| US20080131968A1 (en) * | 2002-08-28 | 2008-06-05 | Nomir Medical Technologies, Inc. | Near-infrared electromagnetic modification of cellular steady-state membrane potentials |
| MXPA06005697A (es) * | 2003-11-19 | 2006-08-17 | Novogen Res Pty Ltd | Composiciones y metodos para radioterapia y quimioterapia en combinacion. |
| AU2005287865B2 (en) | 2004-09-21 | 2012-02-16 | Marshall Edwards, Inc. | Substituted chroman derivatives, medicaments and use in therapy |
| US8080675B2 (en) | 2004-09-21 | 2011-12-20 | Marshall Edwards, Inc. | Chroman derivatives, medicaments and use in therapy |
| EP2084141A4 (de) * | 2006-10-30 | 2010-07-21 | Novogen Res Pty Ltd | Prävention und reversion von durch chemotherapie induzierter peripherer neuropathie |
| US8168661B2 (en) * | 2006-11-06 | 2012-05-01 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
| US8178564B2 (en) * | 2006-11-06 | 2012-05-15 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
| US8168662B1 (en) | 2006-11-06 | 2012-05-01 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
| US8173686B2 (en) | 2006-11-06 | 2012-05-08 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
| US20110033528A1 (en) * | 2009-08-05 | 2011-02-10 | Poniard Pharmaceuticals, Inc. | Stabilized picoplatin oral dosage form |
| TW200916094A (en) * | 2007-06-27 | 2009-04-16 | Poniard Pharmaceuticals Inc | Stabilized picoplatin dosage form |
| US20100260832A1 (en) * | 2007-06-27 | 2010-10-14 | Poniard Pharmaceuticals, Inc. | Combination therapy for ovarian cancer |
| TW200920347A (en) * | 2007-07-16 | 2009-05-16 | Poniard Pharmaceuticals Inc | Oral formulations for picoplatin |
| US8292723B2 (en) * | 2007-11-09 | 2012-10-23 | Igt | Gaming system and method for providing team play |
| US20110053879A1 (en) * | 2008-02-08 | 2011-03-03 | Poniard Pharmaceuticals, Inc. | Picoplatin and amrubicin to treat lung cancer |
| WO2010012037A1 (en) * | 2008-07-30 | 2010-02-04 | Novogen Research Pty Ltd | 6-substituted isoflavonoid compounds and uses thereof |
| US20120156311A1 (en) * | 2009-09-01 | 2012-06-21 | Lu qing-bin | Combination therapy for cancer comprising a platinum-based antineoplastic agent and a biocompatible electron donor |
| EP2635273B1 (de) | 2010-11-01 | 2020-01-08 | MEI Pharma, Inc. | Isoflavonoidzusammensetzungen und verfahren zur krebsbehandlung |
| CN103494838B (zh) * | 2013-09-30 | 2016-05-11 | 武汉大学 | 一种化疗药物组合物 |
| US10980774B2 (en) | 2015-02-02 | 2021-04-20 | Mei Pharma, Inc. | Combination therapies |
| US20190160004A1 (en) * | 2016-04-06 | 2019-05-30 | Noxopharm Limited | Improvements in cancer treatment |
| JP2019513826A (ja) * | 2016-04-06 | 2019-05-30 | ノクソファーム リミティド | 放射線療法の改善 |
| WO2017173498A1 (en) | 2016-04-06 | 2017-10-12 | Noxopharm Limited | Isoflavonoid composition with improved pharmacokinetics |
| US20190117620A1 (en) * | 2016-04-22 | 2019-04-25 | Noxopharm Limited | Chemotherapy improvements |
| CN110312439A (zh) | 2016-10-03 | 2019-10-08 | 夏滉 | 用于增强癌症放射治疗的组合物和方法 |
| IL271327B2 (en) | 2017-06-13 | 2024-11-01 | Simon Hsia Houn | Compositions for increasing tumor sensitivity to hyperthermia therapy |
| JP7788129B2 (ja) | 2017-06-13 | 2025-12-18 | シャー，ホウン・サイモン | 癌化学療法を増強するための組成物および方法 |
| WO2018231937A2 (en) | 2017-06-13 | 2018-12-20 | Houn Simon Hsia | Compositions and methods for enhancing cancer radiotherapy |
| AU2021247415A1 (en) | 2020-03-30 | 2022-09-29 | Noxopharm Limited | Methods for the treatment of inflammation associated with infection |
| CN117599041B (zh) * | 2024-01-22 | 2024-05-03 | 中国人民解放军军事科学院军事医学研究院 | 去氢雌马酚及其衍生物作为新型辐射防护剂和细胞保护剂的医药用途 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4264509A (en) * | 1977-06-08 | 1981-04-28 | Z-L Limited Partnership | Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same |
| GB8626344D0 (en) * | 1986-11-04 | 1986-12-03 | Zyma Sa | Bicyclic compounds |
| JP2514500B2 (ja) | 1991-09-14 | 1996-07-10 | 呉羽化学工業株式会社 | 多剤耐性抑制剤及び発現阻害剤 |
| AUPO203996A0 (en) * | 1996-08-30 | 1996-09-26 | Novogen Research Pty Ltd | Therapeutic uses |
| GB9621757D0 (en) * | 1996-10-18 | 1996-12-11 | Ciba Geigy Ag | Phenyl-substituted bicyclic heterocyclyl derivatives and their use |
| WO1999049862A1 (en) * | 1998-03-30 | 1999-10-07 | The University Of Mississippi | Isoflavones for treating giardiasis and malaria |
| FR2781154B1 (fr) | 1998-07-15 | 2001-09-07 | Lafon Labor | Composition therapeutique a base d'isoflavonoides destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques |
| AUPP868599A0 (en) | 1999-02-15 | 1999-03-11 | Novogen Research Pty Ltd | Production of isoflavone derivatives |
| AUPQ008299A0 (en) | 1999-04-30 | 1999-05-27 | G.J. Consultants Pty Ltd | Isoflavone metabolites |
| AUPQ266199A0 (en) * | 1999-09-06 | 1999-09-30 | Novogen Research Pty Ltd | Compositions and therapeutic methods involving isoflavones and analogues thereof |
| US6380405B1 (en) * | 1999-09-13 | 2002-04-30 | Nobex Corporation | Taxane prodrugs |
| FI20001593A7 (fi) * | 2000-07-03 | 2002-01-04 | Orion Yhtymo Oyj | Comt-entsyymiõ inhiboivaa aktiivisuutta omaavia kumariinijohdannaisia |
| CN1335133A (zh) * | 2000-07-28 | 2002-02-13 | 蛋白质技术国际公司 | 预防或治疗乳腺癌的组合物和方法 |
| EP1503751A4 (de) * | 2002-04-09 | 2007-08-01 | Novogen Res Pty Ltd | Therapeutische verfahren und zusammensetzungen mit isoflav-3-en und isoflavan-strukturen |
-
2002
- 2002-10-02 AU AU2002951833A patent/AU2002951833A0/en not_active Abandoned
-
2003
- 2003-10-02 EP EP03798829A patent/EP1545481A4/de not_active Withdrawn
- 2003-10-02 CA CA002498555A patent/CA2498555A1/en not_active Abandoned
- 2003-10-02 WO PCT/AU2003/001296 patent/WO2004030662A1/en not_active Ceased
- 2003-10-02 CN CN200380100787A patent/CN100591331C/zh not_active Expired - Fee Related
- 2003-10-02 NZ NZ538583A patent/NZ538583A/en not_active Application Discontinuation
- 2003-10-02 MX MXPA05003528A patent/MXPA05003528A/es active IP Right Grant
- 2003-10-02 US US10/530,176 patent/US7906554B2/en not_active Expired - Fee Related
- 2003-10-02 JP JP2004540375A patent/JP2006504705A/ja active Pending
-
2005
- 2005-04-20 NO NO20051941A patent/NO20051941L/no not_active Application Discontinuation
-
2007
- 2007-04-05 US US11/730,985 patent/US20080069900A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1545481A1 (de) | 2005-06-29 |
| WO2004030662A1 (en) | 2004-04-15 |
| US7906554B2 (en) | 2011-03-15 |
| US20060183728A1 (en) | 2006-08-17 |
| NZ538583A (en) | 2008-03-28 |
| MXPA05003528A (es) | 2005-06-03 |
| JP2006504705A (ja) | 2006-02-09 |
| HK1083455A1 (zh) | 2006-07-07 |
| CN1694690A (zh) | 2005-11-09 |
| US20080069900A1 (en) | 2008-03-20 |
| CA2498555A1 (en) | 2004-04-15 |
| EP1545481A4 (de) | 2009-11-11 |
| AU2002951833A0 (en) | 2002-10-24 |
| CN100591331C (zh) | 2010-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20051941L (no) | Kombinasjonskjemoterapisammensetninger og fremgangsmater. | |
| SE0301700D0 (sv) | Novel compounds | |
| CY1116373T1 (el) | Φαρμακευτικα σκευασματα που περιεχουν μεθυλναλτρεξονη | |
| NO20063171L (no) | Endoparasitisidale sammensetninger for topisk anvendelse | |
| NO20064347L (no) | Substituerte 1,2,3,4-tetrahydroisokinolinderivater | |
| DK1951729T3 (da) | Oxygenbundne pyrimidinderivater | |
| SE0301653D0 (sv) | Novel compounds | |
| NO20064584L (no) | Tetrahydropyridoindolderivater | |
| NO20005535D0 (no) | Pyrazol-derivater som P-38 MAP kinase-inhibitorer | |
| NO20085373L (no) | P38 inhibitorer, deres fremstilling og anvendelse | |
| NO20066055L (no) | Pyridinderivater | |
| CY1113282T1 (el) | Αντιικα νουκλεοζιτικα αναλογα | |
| TNSN05254A1 (en) | Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics | |
| UA86591C2 (ru) | Пирролодигидроизохинолины как ингибиторы pde10, фармацевтическая композиция на их основе | |
| MX2007003108A (es) | Compuestos imidazo-3-il-amina sustituidos y biciclicos. | |
| DE60212949D1 (de) | Antivirale pyrazolopyridin verbindungen | |
| DE60334536D1 (de) | Furylverbindungen | |
| NO20062020L (no) | 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika | |
| DK1517890T3 (da) | Kationisk substituerede diphenylazetidinoner, fremgangsmåde til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse | |
| SE0302139D0 (sv) | Novel compounds | |
| SE0303541D0 (sv) | New compounds | |
| UA83648C2 (ru) | Антагонисты аденозиндифосфатного рецептора тромбоцитов | |
| NO20062739L (no) | Kontrollert frigivining av topirimat i flytende doseringsform | |
| SE0102716D0 (sv) | Novel compounds | |
| SE0401871D0 (sv) | New compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |